B Escudier, T Eisen, WM Stadler… - … England Journal of …, 2007 - Mass Medical Soc
Background We conducted a phase 3, randomized, double-blind, placebo-controlled trial of
sorafenib, a multikinase inhibitor of tumor-cell proliferation and angiogenesis, in patients …